|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Career Definitions
Labor Market Reports
Education & Training
Regions
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
Vertex Pharmaceuticals Incorporated (VRTX) Announces the Appointment of Freda C. Lewis-Hall, M.D., as Executive Vice President, Medicines Development
6/18/2008
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced the appointment of Freda C. Lewis-Hall, M.D. as Executive Vice President, Medicines Development. Dr. Lewis-Hall joins Vertex from Bristol-Myers Squibb, Incorporated, and has extensive leadership experience across multiple functional areas in the pharmaceutical industry. At Vertex, Dr. Lewis-Hall will be responsible for Regulatory Affairs, Clinical and Non-clinical Development, Medical Affairs and Commercial Development. Dr. Lewis-Hall will serve on the Company’s executive management team and will report directly to Joshua Boger, Ph.D., President and CEO of Vertex.
|
|
|
|
|
|
|
|
|
|
|
|